CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
HTA, Digital Twins, And Building Clinical Tech That Lasts
ISPOR CEO Rob Abbott on HTA-integrated trial design, digital twin evidence gaps, SaMD’s continuous update problem, and the one change he’d mandate for clinical tech.
-
Real-World Evidence And Wearables Are Reshaping Trial Tech
ISPOR’s Rob Abbott on why RWE moved to number two in the 2026-2027 HEOR Trends Report, and what wearables, data fragmentation, and HARPER+ mean for clinical platforms.
ECOA RESOURCES
-
During this presentation, industry experts provide insights on how clinical trial stakeholders can enrich the participants' journeys in harmony with PFDD objectives.
-
Now, more than ever, sponsors aim to empower the global patient voice through patient-centric technologies—including providing wearable technologies and using electronic clinical outcome assessments (eCOAs) to collect patient data.
-
With the right eSource technology, discover how trial data can be aggregated, integrated, and classified to accelerate data analysis for insight-based decisions in real time.
ECONSENT RESOURCES
-
With the right eSource technology, discover how trial data can be aggregated, integrated, and classified to accelerate data analysis for insight-based decisions in real time.
-
Despite the rise of digital solutions in healthcare, paper consent forms are still common in today’s clinical trials. Unfortunately, these paper forms pose significant challenges in retaining the documentation of informed consent for centrally stored biospecimens.
-
Software vendors often forget to think about the needs of LARs, even though they play a vital role in clinical trials. Explore three ways eConsent can help LARs complete the informed consent process.
EPRO RESOURCES
-
After experiencing paper processing issues, discover how a company transitioned to digital data collection by using Electronic Data Capture (EDC) and Electronic Patient Reported Outcomes (ePRO) solutions.
-
Kelly Dumais, Principal Scientific Advisor, and Jowita Marszewska, Scientific Advisor at Clario eCOA, delve into the specifics of how recent regulatory advancements are influencing PRO Strategy.
-
Explore the transformative impact of flexible ePRO technology on clinical trials, elucidating how it enhances patient-centricity and operational efficiency for sponsors.